Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01235117
Recruitment Status : Completed
First Posted : November 5, 2010
Last Update Posted : August 26, 2013
Information provided by:
National Cancer Institute (NCI)

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2012
  Study Completion Date : May 2013